Valuation : RaySearch Laboratories AB

Market Cap 596.71Cr 62Cr 54Cr 50Cr 46Cr 86Cr 5.91TCr 87Cr 232.38Cr 3.02TCr 234.6Cr 229.49Cr 9.72TCr P/E 2026 *
22.2x
P/E 2027 * 17.8x
Enterprise Value 612.21Cr 64Cr 55Cr 52Cr 47Cr 88Cr 6.06TCr 89Cr 238.42Cr 3.1TCr 240.7Cr 235.45Cr 9.97TCr EV / Sales 2026 *
4.38x
EV / Sales 2027 * 3.66x
Free-Float
80.09%
Yield 2026 *
2.25%
Yield 2027 * 2.69%
1 day+1.25%
1 week-1.99%
Current month-2.39%
1 month-2.28%
3 months-20.45%
6 months-4.95%
Current year-22.36%
1 week 175.9
Extreme 175.9
186.9
1 month 172.8
Extreme 172.8
199.8
Current year 161
Extreme 161
237
1 year 161
Extreme 161
266.5
3 years 78.2
Extreme 78.2
369.5
5 years 40.8
Extreme 40.8
369.5
10 years 40.8
Extreme 40.8
369.5
Manager TitleAgeSince
Chief Executive Officer 57 01/01/2000
Director of Finance/CFO 48 27/01/2025
Chief Tech/Sci/R&D Officer 53 28/08/2015
Director TitleAgeSince
Director/Board Member 57 01/01/2000
Chairman 81 18/11/2016
Chairman 87 30/09/2022
Change 5-day change 1-year change 3-year change Capi.($)
+0.80%-1.99% - - 62Cr
+1.30%+16.12%+5.33%+31.31% 4.55TCr
+0.16%-6.45%-41.39%+136.71% 1.29TCr
+1.54%+5.98%-10.47%+71.66% 573.51Cr
-0.58%+1.57%+59.53% - 434.77Cr
+0.37%+1.24% - - 208.96Cr
+0.32%+4.10%+8.47%-38.96% 158.33Cr
-1.34%-1.68%-34.67% - 109.52Cr
-0.59%-1.96%+51.17%+59.85% 99Cr
+0.39%-1.35%+34.03%+149.76% 100.9Cr
Average +0.17%+2.13%+9.00%+68.39% 835.79Cr
Weighted average by Cap. +0.35%+8.54%-0.45%+55.38%

Financials

2026 *2027 *
Net sales 139.65Cr 15Cr 13Cr 12Cr 11Cr 20Cr 1.38TCr 20Cr 54Cr 706.32Cr 55Cr 54Cr 2.27TCr 163.15Cr 17Cr 15Cr 14Cr 13Cr 24Cr 1.61TCr 24Cr 64Cr 825.17Cr 64Cr 63Cr 2.66TCr
Net income 27Cr 2.85Cr 2.45Cr 2.3Cr 2.1Cr 3.93Cr 269.2Cr 3.96Cr 11Cr 137.57Cr 11Cr 10Cr 443.07Cr 34Cr 3.53Cr 3.04Cr 2.85Cr 2.61Cr 4.87Cr 334.02Cr 4.91Cr 13Cr 170.7Cr 13Cr 13Cr 549.76Cr
Net Debt 16Cr 1.62Cr 1.4Cr 1.31Cr 1.2Cr 2.24Cr 153.4Cr 2.26Cr 6.04Cr 78Cr 6.09Cr 5.96Cr 252.48Cr 70L 7L 6L 6L 5L 10.1L 6.93Cr 10.18L 27.26L 3.54Cr 27.52L 26.92L 11Cr
Logo RaySearch Laboratories AB
RaySearch Laboratories AB (publ) is a Sweden-based medical technology company that develops software for radiation therapy of cancer. It markets and sells its products mainly in the United States and in Europe through license agreements with medical technology companies and scientific institutions. Additionally, its solutions include software for optimizing Intensity Modulated Radiation Therapy (IMRT) plans for photons, adaptive technology for IMRT treatments and software for proton treatments. The Company’s commercial partners are Philips, Nucletron and IBA Dosimetry, among others. In April 2014, it established a German subsidiary, RaySearch Germany GmbH.
Employees
464
Date Price Change Volume
03/26/03 SEK 177.40 +0.80% 0
02/26/02 SEK 176.60 -1.89% 2,008
01/26/01 SEK 180.00 -0.96% 1,147
31/26/31 SEK 181.75 -2.57% 390
28/26/28 SEK 186.55 +3.18% 6,765
Trader
Investor
Global
Quality
ESG MSCI
CCC
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
1
Last Close Price
177.50SEK
Average target price
297.50SEK
Spread / Average Target
+67.61%

Quarterly revenue - Rate of surprise